SOPHiA GENETICS (SOPH) Debt Ratio (2020 - 2025)

SOPHiA GENETICS (SOPH) reported Debt Ratio of 0.29 for Q4 2025, up 243.52% on a YoY basis from 0.09 in Q4 2024, and up 0.58% sequentially from 0.29 in Q3 2025.

SOPHiA GENETICS (SOPH) Debt Ratio (2020 - 2025) Analysis & Trends

SOPHiA GENETICS (SOPH) has 3 years of Debt Ratio data on file, last reported at 0.29 in Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio rose 243.52% year-over-year to 0.29; the trailing twelve-month figure through Dec 2025 stood at 0.29 (up 243.52% YoY), and the FY2025 full-year result was 0.29, up 243.52% from the prior year.
  • Debt Ratio grew to 0.29 in Q4 2025, from 0.29 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.29 in Q4 2025 to a low of 0.07 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn -
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn 0.40
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn 0.29
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn -
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn -
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn -
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn 0.25
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn -
9 Privia Health 3.10 Bn 2.73 Bn - -
10 SOPHiA GENETICS 408.62 Mn 338.33 Mn 14.69 Mn 0.29

Historic Data

Download Data
DateValue
Dec 31, 2025 0.29
Sep 30, 2025 0.29
Jun 30, 2025 0.27
Mar 31, 2025 0.09
Dec 31, 2024 0.09
Sep 30, 2024 0.07
Jun 30, 2024 0.07
Dec 31, 2020 0.03